Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Tampa Bay forecasters say it’s too early to tell where the storm will go, but urged residents to keep an eye on forecasts.

2024 Future of Healthcategory US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder November 13, 2024 ...

MSN is back? Microsoft has revitalized the MSN homepage with a fresh new logo, while seemingly replacing "Start" in many key ...

The life of a dedicated descendent of the designer of the Texas flag is being remembered in Montgomery County. Pat Spackey, 82, has died unexpectedly.

Think logos are tacky? No more. Fashion has shifted from giant Gs and Cs to quiet branding that lets men and women subtly ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

When the colder months approach, having a reliable and efficient heating source becomes a priority. The Snug Heater has emerged as a popular choice among consumers looking to stay warm without ...

Nov 4 (Reuters) - Sam Altman-led OpenAI is in early talks with the California attorney general's office to change its ...

Integration of CLM and PLM enables a streamlined approach to configuration management, leading to faster time to market and more satisfied customers COPENHAGEN, Denmark, Nov. 1, 2024 /PRNewswire/ ...